CHICAGO – (Nov. 26, 2018). Materialise NV (Nasdaq: MTLS), a world leading 3D printing solutions provider, is working with partners to remove uncertainty and confusion for hospitals and physicians who are incorporating 3D printing into their diagnostic and surgical planning processes.
Materialise has launched a certification program that allows printer manufacturers that partner with the company to have products tested and validated as being fully compatible with Materialise Mimics inPrint software. inPrint is the first and only software to gain clearance from the FDA to develop 3D printed anatomical models for diagnostic and surgical planning uses. The inPrint software is printer- and material-agnostic, allowing Materialise to develop partnerships and solutions to meet a range of hospital and clinician requirements.
Ludwigshafen/Germany, Leuven/Belgium, College Station/Texas, USA November 14th, 2018. BASF Venture Capital is leading the Series A investment round in Essentium, Inc., an innovative developer of disruptive, industrial additive manufacturing solutions headquartered in College Station, Texas. Materialise is one of the co-investors in the Series A investment round in Essentium, Inc. BASF and Essentium have been working together on advanced fused filament fabrication (FFF) solutions using Essentium’s proprietary FlashFuseTM technology for high mechanical strength in the build direction for extrusion printed parts. The two companies are now extending their strategic partnership to establish a consistent global materials supply chain supportive of Essentium’s new High Speed Extrusion (HSE) additive manufacturing platform. Essentium and BASF welcome Materialise to enter this strategic partnership to develop 3D printing software for the Essentium technology.
Frankfurt, Germany - November 12, 2018. Materialise introduces 3D printing innovations that increase productivity and efficiency in the 3D printing process. While technological improvements and material advances are driving the development of new applications, industrial print factories are looking for ways to raise output while reducing costs. Meanwhile 3D printing service bureaus are operating in an increasingly cost-competitive environment. At Formnext, Materialise presents software innovations that will help companies to scale their operations, use resources more efficiently, and reduce costs.
Executive Chairman Peter Leys commented, “Following a busy summer, during which we entered into an alliance with BASF and completed both a public offering and a private placement of our equity, raising a total of US $70 million in cash gross proceeds, we are pleased to post yet another set of good results for the third quarter. These results reflect particularly strong performances from our Materialise Medical and Materialise Software segments, and a continuing solid contribution from our ACTech business. We continue to move forward with many innovations to advance the digital manufacturing process and look forward to participating in the Formnext conference in mid-November, where we intend to unveil several innovative products.”
Paris, France – October 3, 2018. A partnership between Materialise, designer Sébastien Brusset and L’Amy has seen a new eyewear range for automotive brand McLaren named ‘Frame Technological Innovation’ of the year at the 2018 Silmo d’Or Awards in Paris. The win is further evidence of 3D printing’s growing importance to the eyewear industry, and of Materialise’s commitment to advancing adoption of the technology.